2012
DOI: 10.3233/jad-2012-120526
|View full text |Cite
|
Sign up to set email alerts
|

Focal Adhesion Kinase Activates NF-κB via the ERK1/2 and p38MAPK Pathways in Amyloid-β25-35-Induced Apoptosis in PC12 Cells

Abstract: Increasing evidence supports that amyloid plaques, comprised of amyloid-β (Aβ), are a key feature of Alzheimer's disease (AD). But the mechanism of Aβ in AD is not yet fully understood. Previous studies have demonstrated that in Aβ-induced apoptosis of nerve cells, differentiated rat pheochromocytoma (PC12) cells, and microglia, nucleus factor kappa B (NF-κB) is activated. Meanwhile, focal adhesion kinase (FAK) is also activated. However, the relationship between NF-κB and FAK remains unclear. Using differenti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
19
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(20 citation statements)
references
References 0 publications
1
19
0
Order By: Relevance
“…It is possible that activation of PDGFRβ, via activation of Erk1/2 and Erk5, promotes the nuclear localization of NF-κB, which increases the transcription of NR4A1. The finding that in amyloid plaques Erk1/2 is activated and directly interacts with IκB kinase promoting NF-κB activation [52] , is consistent with this possibility.…”
Section: Discussionsupporting
confidence: 57%
“…It is possible that activation of PDGFRβ, via activation of Erk1/2 and Erk5, promotes the nuclear localization of NF-κB, which increases the transcription of NR4A1. The finding that in amyloid plaques Erk1/2 is activated and directly interacts with IκB kinase promoting NF-κB activation [52] , is consistent with this possibility.…”
Section: Discussionsupporting
confidence: 57%
“…Suppression of NF‐κB activation provides neuroprotection against Aβ1–42‐dependent neurotoxicity (Yu et al, ). Moreover, NF‐κB activation is mediated by focal adhesion kinase and subsequent extracellular signal‐regulated kinase (ERK) 1/2 and P38MAPK during Aβ25–35‐induced PC12 cell apoptosis (Wang et al, ). Collectively, NF‐κB might be another target for treatment of AD.…”
Section: Discussionmentioning
confidence: 99%
“…These results further validate the suppressive role of Pax-5 on NFκB activation. Studies have also shown that FAK and NFκB can mutually activate each other in cancer processes 41, 55, 56. In this case, the suppressive effects of Pax-5 on each component of the NFκB/FAK cascade would greatly enhance breast cancer cell epithelialisation and inhibit tumor malignancy.…”
Section: Discussionmentioning
confidence: 99%